2023 annual financial data
Radiopharm Theranostics 2023 Operating margin
Radiopharm Theranostics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -11,803.33%.
Operating income was -34,508,085 AUD and net income was -34,611,194 AUD.
Operating cash flow was -23,201,798 AUD.
Get free Radiopharm Theranostics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 292,359 AUD
- Operating income
- -34,508,085 AUD
- Net income
- -34,611,194 AUD
- Operating cash flow
- -23,201,798 AUD